Annual SG&A
$0.00$215.31M-100.00%
Summary
- Current Value
- As of today, CYTK annual SG&A is $0.00, down -100.00% on
- Historical Performance
- CYTK annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
- All-Time High Comparison
- CYTK annual SG&A is currently -100.00% below its historical high of $215.31M set on
- Sector Comparison
- CYTK annual SG&A is higher than 71.98% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $104.40M | +58.9% | +162.8% | +392.5% | +2649.5% | ||
| -$14.37B | -6038.0% | -7603.3% | -10000.0% | -10000.0% | ||
| Price | $69.31 | +40.2% | +102.5% | +105.7% | +737.1% | |
| $612.26M | +12.3% | +49.2% | +551.7% | +1116.9% | ||
| Annual Operating Profit | -$612.26M | -14.2% | -88.8% | -551.7% | -1133.5% | |
| $10.13M | +6.2% | +20.6% | +453.0% | +432.9% | ||
| Annual Revenue | $88.04M | +376.6% | -6.9% | +57.7% | +3316.3% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $215.31M | -100.0% | |
| 5Y | $215.31M | -100.0% | |
| All | $215.31M | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
- What is the current annual SG&A of CYTK?
- As of today, CYTK annual SG&A is $0.00
- What is 1-year change in CYTK annual SG&A?
- CYTK annual SG&A is down -100.00% year-over-year
- What is 3-year change in CYTK annual SG&A?
- CYTK annual SG&A is down -100.00% over the past 3 years
- How far is CYTK annual SG&A from its all-time high?
- CYTK annual SG&A is currently -100.00% below its historical high of $215.31M set on December 31, 2024
- How does CYTK annual SG&A rank versus sector peers?
- CYTK annual SG&A is higher than 71.98% of companies in Healthcare sector
- When is CYTK next annual earnings release?
- As of today, the next annual earnings release for CYTK has not been scheduled
SG&A Formula
SG&A = − − R&D
Quarterly SG&A
$104.40M$499.00K-0.48%
Summary
- Current Value
- As of today, CYTK quarterly SG&A is $104.40M, down -0.48% on
- Historical Performance
- CYTK quarterly SG&A is up +58.85% year-over-year, up +162.82% over the past 3 years
- All-Time High Comparison
- CYTK quarterly SG&A is currently -0.48% below its historical high of $104.90M set on
- 3-Year Low Comparison
- CYTK quarterly SG&A is +162.82% above its 3-year low of $39.72M reached on an earlier date
- Sector Comparison
- CYTK quarterly SG&A is higher than 91.35% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $104.40M | -0.5% | +58.9% | +162.8% | +392.5% | ||
| $0.00 | – | -100.0% | -100.0% | -100.0% | ||
| -$14.37B | -4432.4% | -6038.0% | -7603.3% | -10000.0% | ||
| Price | $69.31 | -2.9% | +40.2% | +102.5% | +105.7% | |
| $198.57M | +0.8% | +12.8% | +65.3% | +262.4% | ||
| Quarterly Operating Profit | -$179.17M | +2.4% | -60.7% | -46.8% | -227.0% | |
| $3.63M | +7.5% | +58.9% | +30.1% | +568.7% | ||
| Quarterly Revenue | $28.62M | +47.9% | -57.1% | +3201.5% | +906.8% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $104.90M | -0.5% | |
| 3Y | $104.90M | -0.5% | |
| 5Y | $104.90M | -0.5% | |
| All | $104.90M | -0.5% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $65.72M | N/A | +58.9% |
| 3Y | $39.72M | N/A | +162.8% |
| 5Y | $21.20M | N/A | +392.5% |
| All | $2.48M | +4118.1% |
Quarterly SG&A History
FAQ
- What is the current quarterly SG&A of CYTK?
- As of today, CYTK quarterly SG&A is $104.40M
- What is CYTK quarterly SG&A most recent change?
- CYTK quarterly SG&A was down -0.48% on June 30, 2026
- What is 1-year change in CYTK quarterly SG&A?
- CYTK quarterly SG&A is up +58.85% year-over-year
- How far is CYTK quarterly SG&A from its all-time high?
- CYTK quarterly SG&A is currently -0.48% below its historical high of $104.90M set on March 31, 2026
- How does CYTK quarterly SG&A rank versus sector peers?
- CYTK quarterly SG&A is higher than 91.35% of companies in Healthcare sector
- When is CYTK next earnings release?
- The next earnings release for CYTK is on
SG&A Formula
SG&A = − − R&D
TTM SG&A
-$14.37B$894.00M-6.63%
Summary
- Current Value
- As of today, CYTK TTM SG&A is -$14.37B, down -6.63% on
- Historical Performance
- CYTK TTM SG&A is down -6037.98% year-over-year, down -7603.30% over the past 3 years
- All-Time High Comparison
- CYTK TTM SG&A is currently -29743.38% below its historical high of $48.49M set on an earlier date
- 3-Year Low Comparison
- CYTK TTM SG&A is at its 3-year low
- Sector Comparison
- CYTK TTM SG&A is higher than 2.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| -$14.37B | -4432.4% | -6038.0% | -7603.3% | -10000.0% | ||
| $0.00 | – | -100.0% | -100.0% | -100.0% | ||
| $104.40M | -0.5% | +58.9% | +162.8% | +392.5% | ||
| Price | $69.31 | -2.9% | +40.2% | +102.5% | +105.7% | |
| TTM Operating Profit | -$707.91M | -10.6% | -29.4% | -46.9% | -459.0% | |
| $12.55M | +12.0% | +33.8% | +20.6% | +501.3% | ||
| TTM Revenue | $67.67M | -36.0% | -21.1% | +580.0% | +17.1% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$11.11B | N/A | -29.3% |
| 3Y | -$6.60B | N/A | -117.9% |
| 5Y | -$4.08B | N/A | -252.2% |
| All | $48.49M | N/A | >-9999.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$14.37B | N/A | at low |
| 3Y | -$14.37B | N/A | at low |
| 5Y | -$14.37B | N/A | at low |
| All | -$14.37B | N/A | at low |
TTM SG&A History
FAQ
- What is the current TTM SG&A of CYTK?
- As of today, CYTK TTM SG&A is -$14.37B
- What is CYTK TTM SG&A most recent change?
- CYTK TTM SG&A was down -6.63% on June 30, 2026
- What is 1-year change in CYTK TTM SG&A?
- CYTK TTM SG&A is down -6037.98% year-over-year
- How does CYTK TTM SG&A rank versus sector peers?
- CYTK TTM SG&A is higher than 2.05% of companies in Healthcare sector
- When is CYTK next earnings release?
- The next earnings release for CYTK is on
SG&A Formula
SG&A = − − R&D
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk
